Northern Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.5M Sell
276,781
-17,027
-6% -$1.94M ﹤0.01% 1382
2025
Q1
$30.9M Buy
293,808
+10,851
+4% +$1.14M ﹤0.01% 1369
2024
Q4
$30.3M Buy
282,957
+20,207
+8% +$2.17M ﹤0.01% 1438
2024
Q3
$26.3M Buy
262,750
+57,847
+28% +$5.79M ﹤0.01% 1453
2024
Q2
$17.3M Sell
204,903
-5,383
-3% -$454K ﹤0.01% 1649
2024
Q1
$15.4M Sell
210,286
-9,494
-4% -$694K ﹤0.01% 1775
2023
Q4
$15.7M Sell
219,780
-101
-0% -$7.21K ﹤0.01% 1787
2023
Q3
$13.2M Buy
219,881
+1,576
+0.7% +$94.4K ﹤0.01% 1817
2023
Q2
$15.7M Buy
218,305
+15,714
+8% +$1.13M ﹤0.01% 1750
2023
Q1
$14.9M Sell
202,591
-686
-0.3% -$50.5K ﹤0.01% 1748
2022
Q4
$13.6M Sell
203,277
-74,223
-27% -$4.96M ﹤0.01% 1800
2022
Q3
$14.9M Sell
277,500
-38,645
-12% -$2.08M ﹤0.01% 1697
2022
Q2
$17.6M Sell
316,145
-8,004
-2% -$446K ﹤0.01% 1617
2022
Q1
$22.7M Sell
324,149
-54,646
-14% -$3.83M ﹤0.01% 1581
2021
Q4
$36.5M Sell
378,795
-3,985
-1% -$384K 0.01% 1337
2021
Q3
$33.3M Sell
382,780
-74,885
-16% -$6.51M 0.01% 1400
2021
Q2
$37.5M Buy
457,665
+80,872
+21% +$6.62M 0.01% 1383
2021
Q1
$35.8M Sell
376,793
-12,667
-3% -$1.2M 0.01% 1393
2020
Q4
$24.2M Sell
389,460
-39,107
-9% -$2.43M ﹤0.01% 1664
2020
Q3
$25.5M Sell
428,567
-48,890
-10% -$2.91M 0.01% 1439
2020
Q2
$33.3M Buy
477,457
+1,829
+0.4% +$128K 0.01% 1211
2020
Q1
$21.6M Sell
475,628
-11,623
-2% -$527K 0.01% 1339
2019
Q4
$31.7M Sell
487,251
-47,455
-9% -$3.09M 0.01% 1362
2019
Q3
$33.2M Sell
534,706
-31,858
-6% -$1.98M 0.01% 1283
2019
Q2
$40.3M Sell
566,564
-35,430
-6% -$2.52M 0.01% 1168
2019
Q1
$47.2M Buy
601,994
+17,842
+3% +$1.4M 0.01% 1002
2018
Q4
$49.5M Buy
584,152
+81,644
+16% +$6.91M 0.01% 861
2018
Q3
$86M Buy
502,508
+3,739
+0.7% +$640K 0.02% 632
2018
Q2
$64.5M Buy
498,769
+3,144
+0.6% +$406K 0.02% 798
2018
Q1
$51.1M Sell
495,625
-3,844
-0.8% -$396K 0.01% 983
2017
Q4
$42.7M Sell
499,469
-5,369
-1% -$459K 0.01% 1103
2017
Q3
$42.9M Sell
504,838
-2,651
-0.5% -$225K 0.01% 1074
2017
Q2
$38.4M Buy
507,489
+35,237
+7% +$2.67M 0.01% 1141
2017
Q1
$31.2M Buy
472,252
+2,347
+0.5% +$155K 0.01% 1309
2016
Q4
$29.8M Sell
469,905
-226,368
-33% -$14.3M 0.01% 1285
2016
Q3
$44.3M Buy
696,273
+30,473
+5% +$1.94M 0.01% 937
2016
Q2
$49.5M Sell
665,800
-12,572
-2% -$935K 0.02% 815
2016
Q1
$42M Sell
678,372
-29,226
-4% -$1.81M 0.01% 921
2015
Q4
$47.9M Buy
707,598
+36,693
+5% +$2.48M 0.02% 829
2015
Q3
$35.8M Sell
670,905
-53,596
-7% -$2.86M 0.01% 1029
2015
Q2
$45.6M Buy
724,501
+34,158
+5% +$2.15M 0.01% 928
2015
Q1
$33.2M Buy
690,343
+17,798
+3% +$856K 0.01% 1181
2014
Q4
$22.3M Buy
672,545
+8,597
+1% +$285K 0.01% 1453
2014
Q3
$19.5M Buy
663,948
+261,885
+65% +$7.68M 0.01% 1530
2014
Q2
$15.6M Sell
402,063
-188,945
-32% -$7.34M ﹤0.01% 1720
2014
Q1
$24.8M Buy
591,008
+125,904
+27% +$5.28M 0.01% 1388
2013
Q4
$15.3M Buy
465,104
+8,663
+2% +$284K ﹤0.01% 1761
2013
Q3
$12.3M Sell
456,441
-9,130
-2% -$246K ﹤0.01% 1867
2013
Q2
$10.9M Buy
+465,571
New +$10.9M ﹤0.01% 1855